Pain
Pain·MeSH: Chronic Pain
293 drugs in development·132 companies·56 clinical trials
Drug Pipeline by Phase
Approved(103)
Phase 3(26)
Phase 2(35)
Phase 1(29)
Preclinical(46)
Unknown(9)
Early Phase 1(8)
N/A(6)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| ST-503 | SANGAMO THERAPEUTICS, INC (SGMO) |
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| ath-1020 | LeonaBio, Inc. (LONA) |
Phase 4(29)
Compare drugs
Frequently asked questions
How many drugs are in development for Pain?
BioSniper tracks 293 drugs in development for Pain across 132 companies.
How many clinical trials target Pain?
There are 56 clinical trials targeting Pain tracked by BioSniper.
Deep-dive into Pain
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis